2026年3月最新《新锐期刊分区表》数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎反馈给我们。
![]() |
体验更多LetPub AI科研工具 >> | |
| 近期推荐: | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 新 聚合物期刊JPM征稿|IF持续上升 + APC折扣 | 热 Springer Nature特刊征稿 |
| |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | Cancer Medicine CANCER MED-US (此期刊被最新的JCR期刊SCIE收录) LetPub评分 6.3
70人评分
我要评分
声誉 6.8 影响力 5.4 速度 7.6 | |||||||||||||||||||||||||
| 期刊ISSN | 2045-7634 | 安装APP,查看期刊最新消息
| ||||||||||||||||||||||||
| 2024-2025最新影响因子 (数据来源于搜索引擎) | 3.1 点击查看影响因子趋势图 | |||||||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日:3.42 | |||||||||||||||||||||||||
| 2024-2025自引率 | 3.2%点击查看自引率趋势图 | |||||||||||||||||||||||||
| 五年影响因子 | 3.5 | |||||||||||||||||||||||||
| JCI期刊引文指标 | 0.68 | |||||||||||||||||||||||||
| h-index | 34 | |||||||||||||||||||||||||
| CiteScore ( 2025年最新版) |
| |||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||
| 期刊官方网站 | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2045-7634 | |||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||
| 期刊投稿网址 | https://mc.manuscriptcentral.com/cancermedicine | |||||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Long-Term Survival Outcomes of Concurrent Chemoradiotherapy for Postoperative High-Risk Salivary Gland Carcinomas Author: Dou, Shengjin; Wang, Xin; Zhang, Lin; Jiang, Wen; Ye, Lulu; Wang, Yu; Li, Rongrong; Zhu, Guopei Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.1002/cam4.71722 LILRB1 Is a Prognostic-Related Biomarker Correlated With Immune Infiltration in Head-Neck Squamous Cell Carcinoma Author: Chen, Shuai; Wu, Qiuwan; Gu, Shuo; Zhou, Yi; Cai, Mingquan; Wu, Junhua; He, Jing; He, Jingjing; Lin, Juli; Hong, Zhicong; Zhang, Binghuang; Luo, Xianyang Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.1002/cam4.71727 Neoadjuvant Therapy for Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma: Current Status, Challenges, and Future Perspectives Author: Zhou, Jiaqi; Guo, Chengwang; Zhang, Mingze; Guo, Xi; Wang, Jihong; Liu, Xiaojun; Nie, Peng; Ma, Yuntao Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.1002/cam4.71753 Characterization of Immune Infiltrating Cells in Bladder Urothelial Carcinoma and Its Clinical Significance Author: Yan, Xin; Tang, Xiaoyu; Guo, Linfa; He, Ziqi; Liu, Shaoxi; Wu, Shaojie; Li, Zhilong; Liu, Tong-zu; Zheng, Hang; Zhang, Weibing; Li, Sheng Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.1002/cam4.71737 | |||||||||||||||||||||||||
| 期刊语言要求 | Language Manuscripts must be written in American English and be grammatically and linguistically correct. Authors should seek assistance with style, grammar and vocabulary if necessary. Your manuscript may also be sent back to you for revision if the quality of English language is poor. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Cancer Medicine的语言要求,还能让Cancer Medicine编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Cancer Medicine编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢(7篇) 。 提交文稿 | |||||||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||||||
OA期刊相关信息![]() | 文章处理费:需要( USD4070; GBP2640; EUR3080; ) 文章处理费豁免:查看说明 其他费用:没有 期刊主题关键词:cancer biology、cancer medicine、cancer prevention、bioinformatics 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||||||
| 通讯方式 | 111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774 | |||||||||||||||||||||||||
| 出版商 | John Wiley and Sons Ltd | |||||||||||||||||||||||||
| 涉及的研究方向 | ONCOLOGY- | |||||||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||
| 出版周期 | ||||||||||||||||||||||||||
| 出版年份 | 0 | |||||||||||||||||||||||||
| 年文章数 | 1046点击查看年文章数趋势图 | |||||||||||||||||||||||||
| Gold OA文章占比 | 96.43% | |||||||||||||||||||||||||
| 研究类文章占比: 文章 ÷(文章 + 综述) | 89.67% | |||||||||||||||||||||||||
| WOS期刊JCR分区 ( 2024-2025年最新版) | WOS分区等级:2区
| |||||||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版:不在预警名单中 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||
| 《新锐期刊分区表》 ( 2026年3月发布) | 点击查看期刊分区表趋势图
| |||||||||||||||||||||||||
| 期刊分区表 ( 2025年3月升级版) |
| |||||||||||||||||||||||||
| 期刊分区表 ( 2023年12月旧的升级版) |
| |||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2045-7634%5BISSN%5D | |||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验: 19 Weeks | |||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验: | |||||||||||||||||||||||||
| 版面费/APC文章处理费信息 | 文章处理费:需要( USD4070; GBP2640; EUR3080; ) 文章处理费豁免:查看说明 其他费用:没有 LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦! | |||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Cancer Medicine顺利发表。
快看看作者怎么说吧:服务好评 论文致谢(7篇) 。 提交文稿 | |||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Long-Term Survival Outcomes of Concurrent Chemoradiotherapy for Postoperative High-Risk Salivary Gland Carcinomas Author: Dou, Shengjin; Wang, Xin; Zhang, Lin; Jiang, Wen; Ye, Lulu; Wang, Yu; Li, Rongrong; Zhu, Guopei Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.1002/cam4.71722 PubMed DOI |
| 2. | LILRB1 Is a Prognostic-Related Biomarker Correlated With Immune Infiltration in Head-Neck Squamous Cell Carcinoma Author: Chen, Shuai; Wu, Qiuwan; Gu, Shuo; Zhou, Yi; Cai, Mingquan; Wu, Junhua; He, Jing; He, Jingjing; Lin, Juli; Hong, Zhicong; Zhang, Binghuang; Luo, Xianyang Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.1002/cam4.71727 PubMed DOI |
| 3. | Neoadjuvant Therapy for Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma: Current Status, Challenges, and Future Perspectives Author: Zhou, Jiaqi; Guo, Chengwang; Zhang, Mingze; Guo, Xi; Wang, Jihong; Liu, Xiaojun; Nie, Peng; Ma, Yuntao Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.1002/cam4.71753 PubMed DOI |
| 4. | Characterization of Immune Infiltrating Cells in Bladder Urothelial Carcinoma and Its Clinical Significance Author: Yan, Xin; Tang, Xiaoyu; Guo, Linfa; He, Ziqi; Liu, Shaoxi; Wu, Shaojie; Li, Zhilong; Liu, Tong-zu; Zheng, Hang; Zhang, Weibing; Li, Sheng Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.1002/cam4.71737 PubMed DOI |
| 5. | Influence of Diagnostic and Treatment Delays on Survival Outcomes in Patients With Locally Advanced Rectal Cancer: A Multi-Center Retrospective Cohort Study Author: Zhao, Yutian; Zhu, Jiahao; Xu, Benjie; Shen, Peipei; Xu, Fei; Yang, Bo; Ji, Shengjun; Zhou, Leyuan Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.1002/cam4.71744 PubMed DOI |
| 6. | Real-World Evidence on Hospitalization Costs of Pediatric Neoplasm Patients in China: Patterns, Trends, and Associated Factors From a Retrospective Cohort Study Author: Zhang, Peng; Zhu, Bifan; Wang, Linan Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.1002/cam4.71635 PubMed DOI |
| 7. | Real-World Efficacy of Nab-Paclitaxel Plus Capecitabine and a PD-1 Inhibitor in Metastatic or Locally Advanced Esophageal Cancer Author: Wang, Yun; Zhang, Wei-Jing; Lu, Yun-Xin; Liu, Shi-Liang; Zhang, Zhuo-Yu; Zhang, Si-Min; Wang, Tian-Wan; Zhong, Yu; Zhang, Dong-Sheng Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.1002/cam4.71735 PubMed DOI |
| 8. | JPH3 Facilitates Cisplatin Resistance in Anaplastic Thyroid Cancer via Activation of the JAK-STAT Signaling Pathway Author: Wang, Xiuyan; Luan, Sha; Sun, Lei; Lian, Lixin; Qi, Ming Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.1002/cam4.71750 PubMed DOI |
| 9. | A Randomized Trial of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or FOLFIRI/Cetuximab in Chinese Patients With BRAFV600E Mutant Metastatic Colorectal Cancer: The NAUTICAL Study Author: Wang, Xicheng; Deng, Yanhong; Zhang, Yanqiao; Liu, Tianshu; Yuan, Xianglin; Yang, Jianwei; Zhang, Tao; Zang, Aimin; Liu, Yu; Huang, Li; Ye, Feng; Zong, Hong; Ba, Yi; Isabelle, Klauck; Jean-claude, Vedovato; Melanie, Groc; Angela, Guo; Li, Jian; Shen, Lin Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.1002/cam4.71697 PubMed DOI |
| 10. | Epidemiology of Risk Stratification, Machine Learning Early Prediction Model, and Tumor Suppressive Mechanism of RHBDF2 in Esophageal Cancer in Gansu Province Author: Zhu, Duojie; Che, Yinggang; Cheng, Huijuan; Wang, Weiqi; Li, Yumin Journal: CANCER MEDICINE. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.1002/cam4.71605 PubMed DOI |
|
|
|
投稿状态统计: 我要评分: | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验:共1335条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号:沪ICP备10217908号-1
沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室